Tag: Cancer: Breast
SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function
Women on aromatase inhibitors exhibit less elasticity in their blood vessels
SABCS: Molecular Changes Occur When Breast CA Spreads to Brain
Finding might lead to better treatment, researchers say
SABCS: No Survival Benefit Seen for Letrozole Beyond Five Years
Study found women who continued with letrozole did experience other benefits, however
Multimodal Breast Cancer Tx May Up Cytokines, Comorbidities
Breast cancer survivors treated with multimodalities have greater burden of comorbid conditions
Biosimilar Promising for ERBB2+ Breast Cancer Treatment
Equivalent response rate for women with ERBB2-positive metastatic breast cancer receiving taxanes
Meds Don’t Cut Trastuzumab-Tied Left Ventricular Remodeling
However, perindopril, bisoprolol do protect against declines in LVEF in HER2-positive early breast cancer
Methylation of Gene Panel May Help Predict Breast CA Survival
High cumulative methylation index linked to shorter median progression-free, overall survival
Palbociclib Efficacious in Metastatic Breast Cancer
Palbociclib-letrozole combination slows disease progression
Cancer Patients Benefit From Exercise During, After Treatment
Studies show better physical function, quality of life for those who did strength training, aerobic activity
Intravaginal Testosterone Deemed Safe in Early Breast CA
Findings in postmenopausal women with early-stage breast cancer receiving aromatase inhibitors
